Lynch syndrome; towards more personalised management?

The lifetime risk of each cancer in people with Lynch syndrome is gene-specific and may be modified by environmental factors.

Furthermore, the benefits of surveillance strategies need to be balanced against the risk of over-diagnosis and be supported by evidence of improved outcomes from cancer diagnosis in surveillance.

Therefore, people with Lynch syndrome may benefit from a personalised management approach.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: